Actions of methylphenidate on dopaminergic neurons of the ventral midbrain

Biological Psychiatry

Volumn 57, Issue 4, 2005, Pages 361-365

  Federici, Mauro ^a   Geracitano, Raffaella ^a   Bernardi, Giorgio ^a,b   Mercuri, Nicola B ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

ADHD; DAT; Dopamine; Methylphenidate; Synaptic transmission; Ventral midbrain

Indexed keywords

CARBIDOPA; DOPAMINE; METHYLPHENIDATE; SULPIRIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG MECHANISM; HYPERPOLARIZATION; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; VOLTAGE CLAMP;

EID: 13444291440     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.11.030     Document Type: Article

References (41)

1. J. Axelrod, R.A. Mueller, J.P. Henry, P.M. Stephens Changes in enzymes involved in the biosynthesis and metabolism of noradrenaline and adrenaline after psychosocial stimulation Nature 225 1970 1059 1060
2. A. Bonci, G. Bernardi, P. Grillner, N.B. Mercuri The dopamine-containing neuron Maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci 24 2003 172 177
3. M.S. Brodie, T.V. Dunwiddie Cocaine effects in the ventral tegmental area Evidence for an indirect dopaminergic mechanism of action Naunyn Schmiedebergs Arch Pharmacol 342 1990 660 665
4. S.A. Burchett, M.J. Bannon Serotonin, dopamine and norepinephrine transporter mRNAs Heterogeneity of distribution and response to 'binge' cocaine administration Brain Res Mol Brain Res 49 1997 95 102
5. S.P. Butcher, J. Liptrot, G.W. Aburthnott Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis Neurosci Lett 122 1991 245 248
6. D.L. Cameron, J.T. Williams Cocaine inhibits GABA release in the VTA through endogenous 5-HT J Neurosci 14 1994 6763 6767
7. D.L. Cameron, J.T. Williams Opposing roles for dopamine and serotonin at presynaptic receptors in the ventral tegmental area Clin Exp Pharmacol Physiol 22 1995 841 845
8. J.G. Chen, A. Sachpatzidis, G. Rudnick The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding J Biol Chem 272 1997 28321 28327
9. K.C. Choong, R.Y. Shen Methylphenidate restores VTA dopamine neuron activity in prenatal ethanol exposed rats by augmenting dopamine neurotransmission J Pharmacol Exp Ther 309 2004 444 451
10. E.H. Cook Jr, M.A. Stein, M.D. Krasowski, N.J. Cox, D.M. Olkon, J.E. Kieffer Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 56 1995 993 998
11. W.C. Drevets, C. Gautier, J.C. Price, D.J. Kupfer, P.E. Kinahan, A.A. Grace Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria Biol Psychiatry 49 2001 81 96
12. R.R. Gainetdinov, M.G. Caron An animal model of attention deficit hyperactivity disorder Mol Med Today 6 2000 43 44
13. R.R. Gainetdinov, M.G. Caron Genetics of childhood disorders: XXIV: ADHD, part 8: Hyperdopaminergic mice as an animal model of ADHD J Am Acad Child Adolesc Psychiatry 40 2001 380 382
14. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
15. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
16. A.A. Grace, S.P. Onn Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro J Neurosci 9 1989 3463 3481
17. E.D. Hendley, S.H. Snyder, J.J. Fauley, J.B. LaPidus Stereoselectivity of catecholamine uptake by brain synaptosomes Studies with ephedrine, methylphenidate and phenyl-2-piperidyl carbinol J Pharmacol Exp Ther 183 1972 103 116
18. R.D. Hunt, D.J. Cohen, G. Anderson, L. Clark Possible change in noradrenergic receptor sensitivity following methylphenidate treatment Growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity Life Sci 35 1984 885 897
19. M. Ishimatsu, Y. Kidani, A. Tsuda, T. Akasu Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus J Neurophysiol 87 2002 1206 1212
20. S. Izenwasser, A.E. Coy, B. Ladenheim, R.J. Loeloff, J.L. Cadet, D. French Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine Eur J Pharmacol 373 1999 187 193
21. S.W. Johnson, N.B. Mercuri, R.A. North 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons J Neurosci 12 1992 2000 2006
22. A. Kirley, N. Lowe, Z. Hawi, C. Mullins, G. Daly, I. Waldman Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD Am J Med Genet 121B 2003 50 54
23. B.K. Koe Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain J Pharmacol Exp Ther 199 1976 649 661
24. M.G. Lacey, N.B. Mercuri, R.A. North Actions of cocaine on rat dopaminergic neurones in vitro Br J Pharmacol 99 1990 731 735
25. N.B. Mercuri, A. Bonci, P. Calabresi, A. Stefani, G. Bernardi Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons Eur J Neurosci 7 1995 462 469
26. E. Meririnne, A. Kankaanpaa, T. Seppala Rewarding properties of methylphenidate Sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists J Pharmacol Exp Ther 298 2001 539 550
27. G.G. Nomikos, G. Damsma, D. Wenkstern, H.C. Fibiger In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis Synapse 6 1990 106 112
28. G.V. Rebec, D.S. Segal Dose-dependent biphasic alterations in the spontaneous activity of neurons in the rat neostriatum produced by d-amphetamine and methylphenidate Brain Res 150 1978 353 366
29. M.C. Ritz, R.J. Lamb, S.R. Goldberg, M.J. Kuhar Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 237 1987 1219 1223
30. S.B. Ross Antagonism by methylphenidate of the stereotyped behaviour produced by (+)-amphetamine in reserpinized rats J Pharm Pharmacol 30 1978 253 254
31. D.N. Ruskin, D.A. Bergstrom, A. Shenker, L.E. Freeman, D. Baek, J.R. Walters Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action Biol Psychiatry 49 2001 340 350
32. V. Sandoval, E.L. Riddle, G.R. Hanson, A.E. Fleckenstein Methylphenidate redistributes vesicular monoamine transporter-2 Role of dopamine receptors J Neurosci 22 2002 8705 8710
33. D.S. Segal, R. Kuczenski Escalating dose-binge treatment with methylphenidate Role of serotonin in the emergent behavioral profile J Pharmacol Exp Ther 291 1999 19 30
34. L. Shuster, J. Hudson, M. Anton, D. Righi Sensitization of mice to methylphenidate Psychopharmacology (Berl) 77 1982 31 36
35. M. Stathis, U. Scheffel, S.Z. Lever, J.W. Boja, F.I. Carroll, M.J. Kuhar Rate of binding of various inhibitors at the dopamine transporter in vivo Psychopharmacology (Berl) 119 1995 376 384
36. J.M. Swanson, N.D. Volkow Serum and brain concentrations of methylphenidate Implications for use and abuse Neurosci Biobehav Rev 27 2003 615 621
37. N.D. Volkow, J.S. Fowler, G. Wang, Y. Ding, S.J. Gatley Mechanism of action of methylphenidate Insights from PET imaging studies J Atten Disord 6 suppl 1 2002 S31 S43
38. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J Neurosci 21 2 2001 RC121
39. N.D. Volkow, G.J. Wang, J.S. Fowler, S.J. Gatley, J. Logan, Y.S. Ding Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high" J Pharmacol Exp Ther 288 1999 14 20
40. H.K. Wayment, H. Deutsch, M.M. Schweri, J.O. Schenk Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter Potential as amphetamine antagonists? J Neurochem 72 1999 1266 1274
41. Y.N. Wu, N.B. Mercuri, S.W. Johnson Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons J Pharmacol Exp Ther 273 1995 576 581